The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

September 1988

Volume 28, Issue 9

Pages 769–864

  1. Pharmacokinetics

    1. Top of page
    2. Pharmacokinetics
    3. Regulatory Affairs
    4. Therapeutic Review
    5. Cardiovascular Diseases
    6. Drugs and Renal Disease
    7. Pharmacokinetics
    8. Central Nervous System Drugs
    1. Combined Pharmacokinetic/ Pharmacodynamic (PK/PD) Modeling (pages 769–771)

      Wayne A. Colburn

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03215.x

  2. Regulatory Affairs

    1. Top of page
    2. Pharmacokinetics
    3. Regulatory Affairs
    4. Therapeutic Review
    5. Cardiovascular Diseases
    6. Drugs and Renal Disease
    7. Pharmacokinetics
    8. Central Nervous System Drugs
    1. Drug Regulation in South Africa (pages 772–778)

      Prof. P. I. Folb, Dr. M. Haus and Mr. J. Schlebusch

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03216.x

  3. Therapeutic Review

    1. Top of page
    2. Pharmacokinetics
    3. Regulatory Affairs
    4. Therapeutic Review
    5. Cardiovascular Diseases
    6. Drugs and Renal Disease
    7. Pharmacokinetics
    8. Central Nervous System Drugs
    1. Differentiation of Leukemia Cells by Chemotherapeutic Agents (pages 779–794)

      Edward L. Schwartz and Peter H. Wiernik

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03217.x

  4. Cardiovascular Diseases

    1. Top of page
    2. Pharmacokinetics
    3. Regulatory Affairs
    4. Therapeutic Review
    5. Cardiovascular Diseases
    6. Drugs and Renal Disease
    7. Pharmacokinetics
    8. Central Nervous System Drugs
    1. Pharmacologic Effects of A-56234, a New High-Ceiling Diuretic (pages 795–803)

      Robert R. Luther, Gary L. Ringham, Elizabeth W. Thomas, Karen J. Patterson and Keith G. Tolman

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03218.x

    2. The Effect of Encapsulated, Low-Dose Colestipol in Patients with Hyperlipidemia (pages 804–806)

      Otto I. Linet, Cynthia R. Grzegorczyk and Donald M. Demke

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03219.x

    3. Improved Exercise Tolerance by IV Fructose-l,6-Diphosphate in Chronic, Stable Angina Pectoris (pages 807–811)

      Niccolo' Marchionni, Guya Moschi, Mauro DI Bari, Luigi Ferrucci, Marco Paoletti, Bernardo Salani and Francesco Fattirolli

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03220.x

    4. Efficacy and Pharmacokinetics of Oral Pirmenol, A New Antiarrhythmic Drug (pages 812–817)

      Dyal C. Garg, Nader S. Jallad, Sharanjeet Singh, Kevin F. Ng and Donald J. Weidler

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03221.x

  5. Drugs and Renal Disease

    1. Top of page
    2. Pharmacokinetics
    3. Regulatory Affairs
    4. Therapeutic Review
    5. Cardiovascular Diseases
    6. Drugs and Renal Disease
    7. Pharmacokinetics
    8. Central Nervous System Drugs
    1. Epoprostenol (PGI2, Prostacyclin) During High-Risk Hemodialysis: Preventing Further Bleeding Complications (pages 818–825)

      Dr. Richard D. Swartz, Drs. Walter Flamenbaum, Alan Dubrow, Drs. Jane C. Hall MS, James W. Crow and Alan Cato

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03222.x

    2. Pharmacokinetics of Iothalamate in Endstage Renal Disease (pages 826–830)

      J. Robert Evans, Ralph E. Cutler and Steven C. Forland

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03223.x

    3. An Evaluation of the Pharmacokinetics, Pharmacodynamics, and Dialyzability of Verapamil in Chronic Hemodialysis Patients (pages 831–836)

      James J. Hanyok, Moses S.S. Chow, Jeffrey Kluger and Mark W. Izard

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03224.x

  6. Pharmacokinetics

    1. Top of page
    2. Pharmacokinetics
    3. Regulatory Affairs
    4. Therapeutic Review
    5. Cardiovascular Diseases
    6. Drugs and Renal Disease
    7. Pharmacokinetics
    8. Central Nervous System Drugs
    1. Pharmacokinetics of 2‘,3’-Dideoxycytidine in Patients with AIDS and Related Disorders (pages 837–842)

      Raymond W. Klecker Jr, Jerry M. Collins, Robert C. Yarchoan, Rose Thomas, Nanette McAtee, Samuel Broder and Charles E. Myers

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03225.x

    2. Correlation Between Verapamil Plasma Concentration and P-R Prolongation in Essential Hypertension (pages 843–847)

      Prince K. Zachariah, Clarence Shub, Sheldon G. Sheps, Alexander Schirger, Mary K. Wolf and Christopher A. Carlson

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03226.x

    3. Effects of Food on the Bioavailability of CGS 16617, an Angiotensin-Converting Enzyme Inhibitor, in Healthy Subjects (pages 848–852)

      Drs. R. Leslie Choi, Gregory M. Kochak, Ms. Patricia Reydel-Bax and Dr. Edward B. Nelson

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03227.x

  7. Central Nervous System Drugs

    1. Top of page
    2. Pharmacokinetics
    3. Regulatory Affairs
    4. Therapeutic Review
    5. Cardiovascular Diseases
    6. Drugs and Renal Disease
    7. Pharmacokinetics
    8. Central Nervous System Drugs
    1. Desmethyldiazepam Pharmacokinetics: Studies Following Intravenous and Oral Desmethyldiazepam, Oral Clorazepate, and Intravenous Diazepam (pages 853–859)

      David J. Greenblatt, Marcia K. Divoll, Ms. May H. Soong, Dr. Harold G. Boxenbaum, Jerold S. Harmatz and Richard I. Shader

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03228.x

    2. Influence of Hypo and Hyperthermia on Disposition of Morphine (pages 860–864)

      Mylarrao Bansinath, Herman Turndorf and Dr. Margarita M. Puig

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1988.tb03229.x

SEARCH

SEARCH BY CITATION